SEATTLE (AP) — SEATTLE (AP) — CTI BioPharma Corp. (CTIC) on Monday reported a loss of $13.4 million in its first quarter.
The Seattle-based company said it had a loss of 10 cents per share.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 10 cents per share.
The biotechnology company posted revenue of $24.1 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $22.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CTIC">Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC